SCHEMBL7985473

SCHEMBL7985473

CN(C(=O)OC(C)(C)C)c1ccc(-c2nc3ncn(Cc4ccccc4)c3c(=O)[nH]2)cc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.46
ALDH1A1 P00352 2/20 0.46
KMT2A Q03164 1/20 0.44
PAX8 Q06710 1/20 0.43
ADORA2B P29275 2/20 0.38
PRMT5 O14744 4/20 0.37
MCL1 Q07820 1/20 0.36
GAA P10253 1/20 0.36
PARN O95453 1/20 0.36
CNOT7 Q9UIV1 1/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
GUSB P08236 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
BRD4 O60885 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984727 0.91 HPGD (0.40) HPGDSMN1; SMN2ALDH1A1KMT2APAX8
SCHEMBL7974152 0.91 HPGD (0.47) HPGDSMN1; SMN2ALDH1A1KMT2APAX8
SCHEMBL7985482 0.86 PAX8 (0.43) HPGDSMN1; SMN2ALDH1A1PAX8ADORA2B
SCHEMBL7988789 0.83 BRD4 (0.40) HPGDSMN1; SMN2ALDH1A1KMT2APAX8
SCHEMBL7984479 0.83 HPGD (0.52) HPGDSMN1; SMN2ALDH1A1KMT2APRMT5
SCHEMBL7985478 0.82 PAX8 (0.45) HPGDSMN1; SMN2ALDH1A1PAX8MCL1
SCHEMBL7985463 0.80 HPGD (0.52) HPGDSMN1; SMN2ALDH1A1KMT2AMCL1
SCHEMBL7975265 0.80 SMN1; SMN2 (0.61) HPGDSMN1; SMN2ALDH1A1KMT2AADORA2B
SCHEMBL7974033 0.79 HPGD (0.49) HPGDSMN1; SMN2ALDH1A1KMT2AMCL1
SCHEMBL7988556 0.79 SMN1; SMN2 (0.58) HPGDSMN1; SMN2ALDH1A1KMT2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed